​These are abstracts from Peter Rossing, PI at SDCC:

• Reduction in Albuminuria Is Associated with Cardiorenal Protection Independent of Baseline Albuminuria – A Post-Hoc Analysis of the LEADER Trial
  [TH-OR034]
  October 25, 2018 | 05:06 PM - 05:18 PM
  Location: 5A, San Diego Convention Center
  
• Myocardial Flow Reserve Assessed by Cardiac 82Rb PET/CT Is Associated with Albumin Excretion in Patients with Type 1 Diabetes
  [FR-PO429]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Pulse Wave Velocity Is an Independent Risk Factor for Cardiovascular Events, Mortality and Decline in Renal Function in Patients with Type 1 Diabetes
  [FR-PO430]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Exome Wide Association Study Identifies a Rare Coding Variant in Cubilin Gene and Suggestive Variants in Additional Genes Associated with Albuminuria Among 33,985 Europeans with and Without Diabetes
  [FR-PO431]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Plasma Lipids Are Associated with Diabetic Kidney Disease: A Study of Plasma Lipidomics in Type 1 Diabetes
  [FR-PO445]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Plasma Metabolomics Identifies Markers of Impaired Kidney Function: A Meta-Analysis of 1,984 Europeans with Type 2 Diabetes
  [FR-PO446]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Cathepsin D: A Potential Biomarker for Diabetic Kidney Disease
  [FR-PO449]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Soluble Urokinase Plasminogen Activator Receptor Predicts Kidney Function Decline and Mortality in Patients with Type 1 Diabetes
  [FR-PO453]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Event, and Mortality in Patients with Type 1 Diabetes
  [FR-PO454]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Urine Metabolites Predict Kidney Function Decline in Type I Diabetic Subjects
  [FR-PO459]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Increasing Baseline Albuminuria Is Associated with a Continuously Increased Risk of Cardiovascular (CV) and Renal Outcomes in the LEADER Trial
  [FR-PO462]
  October 26, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers
  [SA-OR081]
  October 27, 2018 | 05:06 PM - 05:18 PM
  Location: 1B, San Diego Convention Center
  
• Effects of Dapagliflozin on Albuminuria, Renal Function, and Renin-Angiotensin-Aldosterone Hormones in Type 2 Diabetes
  [SA-PO138]
  October 27, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Effect of Dapagliflozin on Cardiac Function and Biomarkers in Patients with Type 2 Diabetes and Albuminuria – A Randomized Study
  [SA-PO139]
  October 27, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center
  
• Acute Hyperoxia and Slow Deep Breathing Improve Baroreflex Sensitivity in Long-Duration Type 1 Diabetes Irrespective of Macroalbuminuria
  [SA-PO158]
  October 27, 2018 | 10:00 AM - 12:00 PM
  Location: Exhibit Hall, San Diego Convention Center